Desmoid Tumor Completed Phase 2 Trials for Nirogacestat (DB12005)

Also known as: Desmoid-Type Fibromatosis / Desmoid Type-fibromatosis / Aggressive Fibromatosis / Desmoid tumour / Fibromatosis, Aggressive / Desmoid Tumors / Fibromatosis Desmoid / Desmoid Fibromatosis / Aggressive fibromatosis (disorder) / Aggressive fibromatosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0028471 (Desmoid Tumor)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01981551Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive FibromatosisTreatment